证券代码：688202 证券简称：美迪西 公告编号：2025-042 上海美迪西生物医药股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： ? 股东持有的基本情况 截至本公告披露日，上海美迪西生物医药股份有限公司（以下简称"公司"） 股东林长青先生持有公司股份 5,473,654 股，占公司总股本的 4.07%，与其一致 行动人陈国兴先生合计持有公司股份10,348,808股，占公司总股本的 7.70%。 上述股份来源于公司 IPO 前取得的股份以及公司实施资本公积金转增股本， 林长青的股份已于 2022 年 11 月 7 日起解禁上市流通。 ? 减持计划的主要内容 因股东自身资金需求，公司股东林长青拟通过集中竞价或大宗交易的方式减 持合计不超过所持公司股票 2,000,000 股，即不超过公司总股本的 1.49%，自减 持计划披露之日起 15 个交易日后的 3 个月内（根据中国证监会及上海证券交易 所规定禁止减持的期间除外）实施。 上述股份减持价格按减持实施时的 ...

Group 1: Company Developments - Hong Kong Airlines has launched a free airport transfer service in collaboration with 永东直通巴士有限公司 and 日本阿拉丁集团, available until December 31, 2025, for passengers with valid boarding passes [1] - 京东币链科技 has reported that a fake digital currency named JD-HKD has been circulating on major trading platforms, clarifying that no such stablecoin has been issued and urging users to avoid scams [1] - 一亩田集团 has established an international business operation center in Hong Kong, marking the beginning of its global expansion, with active buyers from over 50 countries [2] - 宇树科技 has initiated its listing guidance with 中信证券 as the advisory firm, with its controlling shareholder holding 34.763% of the company [3] - 必和必拓 has announced that its Canadian potash project may exceed budget by $1.7 billion, with the first phase 68% complete and initial production now expected in mid-2027 [4] - 英国石油 has agreed to sell its onshore wind energy business in the U.S. to LS Power [4] - 比亚迪 has established a new sales service company in Jinan, fully owned by its subsidiary [4] - 小米 has officially opened its Shenzhen headquarters, marking its fourth regional headquarters in China [6] - 赛诺菲 has completed the acquisition of Blueprint Medicines for over $9 billion, including a rare disease drug that has been approved in the U.S. and EU [6] - 保泰人寿 has secured $70 million in Series C funding, led by 永明金融有限公司 [6] - 长石资本 has raised 728 million yuan for its hard technology fund, achieving over 50% IPO success rate across its investments [6] Group 2: Product and Partnership Announcements - 腾讯元宝 has integrated with QQ Music, allowing users to play music directly within the app [7] - Airwallex has formed a multi-year global partnership with Arsenal Football Club, becoming the official financial software partner [8] Group 3: Market Insights - The global cryptocurrency market has surpassed $4 trillion for the first time, with Bitcoin accounting for 59.91% of the total market cap at approximately $2.39 trillion [12]

图片来源：视觉中国 蓝鲸新闻7月18日讯（记者 李丹萍）随着市场认知的不断提升，以及新《证券法》、新《公司法》陆续实施的推动，A股上市公司的董责险热度持续攀升。 据蓝鲸新闻记者不完全统计，截至2025年7月18日，2025年共有300余家上市公司对外披露投保计划，与去年同期相比基本持平。 若从业内数据来看，据平安产险不完整统计，我国A股上市公司的董责险投保率已从2019年底的不足8%（约3800家上市公司为基数），提升至2025年5月底 的28.4%（约5380家上市公司为基数），已投保A股上市公司数量由2019年的约300家提升至2025年5月底的超过1500家，已实现渗透率的大幅增长。不过， 与海外成熟市场相比仍有较大的提升空间。 总的来看，影响因素包括整体风险意识不足，经济环境带来的降本增效压力，以及部分企业股权集中度较高，大股东或实际控制人对公司经营决策把控力度 较强，部分董事的投保需求被忽视。 记者不完全梳理，今年以来，已有超过300家上市公司披露了拟购买董责险的公告，数量与去年同期基本持平。从上市公司公告来看，董责险的保险期限一 般为一年，多数保费为数十万元，常见的保单限额为5千万元或1亿元。 某 ...

科创板设立六年以来，凭借高度创新的市场机制及包容的融资环境，为中国科技创新企业提供了更为优良的发展平台。随着"科创板八条"、"1+6" 政策等陆 续推出，以及一揽子更具包容性和适应性的配套制度持续落地，优质科技型企业发展的难点堵点有望陆续疏通，科创板将为我国经济转型和新质生产力的发 展持续注入充足动能。 上海证券交易所与第一财经联合策划推出的《价值与投资》栏目，2025年第二期节目以"科创板六周年：资本助新，产业焕新"为主题，邀请科创板上市公司 董事长、上海交通大学教授、中证指数公司代表，详细解析资本助力下，科创企业持续发展壮大，并以科技创新为产业赋能的历程。 多方助力科创企业跨越成长周期 "正是有了科创板提供的种种金融支持，大大增强了企业的抗风险能力，博瑞医药得以在创新药研发方面持续快速推进。"袁建栋说。 在资本的有力支持下，博瑞医药六年累计研发投入达到12亿元，目前已有四条在研创新药管线，其中最重要的创新药物BGM0504注射液已进入III期临床， 公司正迎来创新药产品商业化前的关键时刻。 皓元医药董事长兼总经理郑保富介绍称，作为服务创新药产业链条的CRO企业，皓元医药成功登陆科创板后也迎来了快速发展的机 ...

截至7月18日收盘，禽流感概念下跌0.90%，位居概念板块跌幅榜前列，板块内，之江生物、生物股 份、中牧股份等跌幅居前，股价上涨的有10只，涨幅居前的有蔚蓝生物、联环药业、温氏股份等，分别 上涨1.38%、0.66%、0.53%。 | 代码 | 简称 | 今日涨跌幅（%） | 今日换手率（%） | 主力资金流量（万元） | | --- | --- | --- | --- | --- | | 600201 | 生物股份 | -5.56 | 11.26 | -12796.79 | | 002317 | 众生药业 | -0.45 | 8.88 | -9342.33 | | 600129 | 太极集团 | -0.27 | 1.82 | -3518.13 | | 688317 | 之江生物 | -7.07 | 7.87 | -3351.04 | | 002688 | 金河生物 | -1.59 | 3.95 | -2607.30 | | 600195 | 中牧股份 | -3.90 | 3.67 | -2531.73 | | 300119 | 瑞普生物 | -1.51 | 5.00 | -2204.22 | | 00099 ...

Market Performance - The Sci-Tech Innovation Board (STAR Market) index rose by 0.19%, closing at 1007.53 points, with a total trading volume of 3.622 billion shares and a turnover of 124.775 billion yuan, resulting in an average turnover rate of 2.02% [1] - Among the tradable stocks on the STAR Market, 324 stocks closed higher, with 9 stocks experiencing a rise of over 10%, including Electric Wind Power, Fumiao Technology, and Shangwei New Materials, which hit the daily limit [1] - The distribution of turnover rates shows that 2 stocks had turnover rates exceeding 20%, 24 stocks had rates between 10% and 20%, and 59 stocks had rates between 5% and 10% [1] High Turnover Stocks - The stock with the highest turnover rate was Xinyuren, which closed up by 3.51% with a turnover rate of 23.24% and a transaction amount of 368 million yuan [3] - Other notable stocks included Aerospace Nanhu, which rose by 5.00% with a turnover rate of 20.06%, and Suochen Technology, which had a turnover rate of 19.66% [3] Sector Analysis - In terms of sector performance, the pharmaceutical and biotechnology sector had the most stocks with a turnover rate exceeding 5%, totaling 32 stocks, followed by the computer and electronics sectors with 18 and 7 stocks, respectively [2] - Among the high turnover stocks, 58 stocks rose today, with Fumiao Technology, Olin Biology, and DeMa Technology leading with increases of 20.02%, 18.93%, and 14.74%, respectively [2] Capital Flow - In terms of capital flow, 48 stocks with high turnover rates saw net inflows from main funds, with the highest net inflows recorded for Youkede, Kaiyin Technology, and Rongchang Biology, amounting to 104 million yuan, 9.403 million yuan, and 6.991 million yuan, respectively [2] - Conversely, the stocks with the largest net outflows included Guokexingong, Maiwei Biology, and Jiayuan Technology, with net outflows of 239 million yuan, 16.9 million yuan, and 13.4 million yuan, respectively [2] Leverage Fund Movements - A total of 51 stocks with high turnover rates recently received net purchases from leveraged funds, with notable increases in financing balances for Gaoce Shares, Shijia Photon, and Weixin Biology, which saw increases of 72.986 million yuan, 71.531 million yuan, and 71.373 million yuan, respectively [2]

Economic Growth and Consumption - Consumption has contributed approximately 60% to economic growth during the "14th Five-Year Plan" period, highlighting its role as a main engine for growth [1][3] - The total retail sales of consumer goods in China is expected to exceed 50 trillion yuan this year, reflecting strong domestic consumption [2][3] Trade Performance - China's goods trade scale remains the largest globally, with export and import market shares stable at over 14% and 10% respectively [5][6] - The service trade scale ranks second globally, surpassing 1 trillion USD for the first time last year [6] Foreign Investment - China has completed its foreign investment target of 700 billion USD six months ahead of schedule, with actual foreign investment reaching 708.73 billion USD by mid-2023 [8][9] - The negative list for foreign investment access continues to shrink, with all restrictions in the manufacturing sector eliminated [9] Consumption Structure and Innovation - Service consumption has seen rapid growth, with an average annual increase of 9.6% from 2020 to 2024 [3][4] - New consumption models, such as "artificial intelligence + consumption" and "IP + consumption," are emerging as new growth points [3][4] International Trade Relations - The diversification of trade partners is evident, with ASEAN being China's largest trading partner for five consecutive years [7] - The proportion of trade with countries involved in the Belt and Road Initiative is expected to exceed 50% by 2024 [7]

资金流向方面，科创板百元股今日主力资金合计净流出1.29亿元，净流入资金居前的有拓荆科技、寒武 纪、恒玄科技等，净流入资金分别为4556.25万元、3631.48万元、3030.31万元；净流出资金居前的有海 光信息、百济神州、金山办公等，净流出资金分别为15785.72万元、6653.65万元、3030.46万元。 融资融券方面，百元股最新（7月17日）融资余额合计258.11亿元，融资余额居前的有寒武纪、海光信 息、中微公司等，最新融资余额分别为37.12亿元、32.60亿元、27.76亿元。最新融券余额合计为1.63亿 元，融券余额居前的有海光信息、寒武纪、惠泰医疗等，最新融券余额分别为0.17亿元、0.12亿元、 0.12亿元。 以最新收盘价计算，科创板平均股价为31.78元，其中股价超100元的有41只，股价最高的是寒武纪。 证券时报·数据宝统计显示，科创板股今日上涨的有324只，下跌的有257只，以收盘价为基准测算，科 创板平均股价为31.78元，其中，收盘价超过100元的有41只，股价在50元至100元之间的有121只，股价 在30元至50元的有167只。 科创板股中，收盘价最高的是寒武纪，今日 ...

齐鲁晚报.齐鲁壹点马玉姝 4月22日，天津市药品监督管理局发布公告称，天津未名在GMP符合性检查中未达规范要求，被采取暂停生产、销售风险控制措 施。 7月4日，因实验进度未及预期，天津未名预计在三个月内无法恢复正常生产经营活动。这一核心生产主体的持续停摆，导致未 名医药于7月8日被深交所实施其他风险提示，股票名称变更为"ST未名（002581）"，股票交易涨跌幅限制由10%变为5%。 海岱财经梳理获知，天津未名生产、销售的人干扰素药品是支撑未名医药营收的主要来源。据财报显示，2024年，天津未名实 现营业收入2.16亿元，净利润-1400.37万元，分别占同期未名医药营业收入的60%，合并报表净利润的9.8%，对收入规模贡献最 大。 截至目前，淄博共有2家A股上市公司被实施其他风险警示(ST)。另一家山东联创产业发展集团股份有限公司(简称"联创股份")于 3月25日起被实施ST警示。 据联创股份最新业绩披露，公司一季度实现营业收入1.6亿元，同比增长12.20%；净利润从去年同期-1555.44万元增长至501.64万 元，同比增长132.25%。 资本市场的连锁反应仍在持续。 7月17日晚间，山东未名生物医 ...

证券代码:002880 证券简称:卫光生物 公告编号:2025-030 深圳市卫光生物制品股份有限公司 相关主体承诺的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 深圳市卫光生物制品股份有限公司（以下简称"公司"）于2025年7月17日 召开第四届董事会第一次会议，审议通过了《关于2025年度向特定对象发行A股 股票摊薄即期股东回报、填补措施及相关主体承诺的议案》。根据《国务院办公 厅关于进一步加强资本市场中小投资者合法权益保护工作的意见》（国办发 2013110号）、《国务院关于进一步促进资本市场健康发展的若干意见》（国发 201417号）及《关于首发及再融资、重大资产重组摊薄即期回报有关事项的指 导意见》（中国证券监督管理委员会公告201531号）的相关要求，为保障中小 投资者利益，公司就2025年度向特定对象发行A股股票（以下简称"本次发行"） 摊薄即期回报对公司主要财务指标的影响进行了分析，并提出了拟采取的填补回 报措施，相关主体对公司填补回报措施能够得到切实履行作出了承诺，具体情况 说明如下： 一、本次发行摊薄即期回报对公司主要财务指标的影响 ...